2-(2-Chloropyridin-3-yl)-5,6-dimethyl-1-[(4-methylphenyl)methyl]-1H-1,3-benzodiazole

Catalog No. :
ACOTOA625
CAS No. :
860787-68-4
Molecular Formula :
C22H20ClN3
Molecular Weight :
361.88

IUPAC Name:2-(2-chloropyridin-3-yl)-5,6-dimethyl-1-(4-methylbenzyl)-1H-benzo[d]imidazole

2-(2-Chloropyridin-3-yl)-5,6-dimethyl-1-[(4-methylphenyl)methyl]-1H-1,3-benzodiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(2-Chloropyridin-3-yl)-5,6-dimethyl-1-[(4-methylphenyl)methyl]-1H-1,3-benzodiazole
IUPAC Name2-(2-chloropyridin-3-yl)-5,6-dimethyl-1-(4-methylbenzyl)-1H-benzo[d]imidazole
MDL No.MFCD04124636
Molecular FormulaC22H20ClN3
Molecular Weight361.88
SMILESCC1=CC=C(CN2C(C3=CC=CN=C3Cl)=NC4=CC(C)=C(C)C=C42)C=C1
InChI KeyXUDBWDNFQTZNHF-UHFFFAOYSA-N
Synonym2-(2-chloropyridin-3-yl)-5,6-dimethyl-1-[(4-methylphenyl)methyl]-1H-1,3-benzodiazole;1H-Benzimidazole, 2-(2-chloro-3-pyridinyl)-5,6-dimethyl-1-[(4-methylphenyl)methyl]-
CAS No.860787-68-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOTOA625 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOTOA625 route product structure diagram
    ACOTOA625860787-68-4
Inquiry

2. ACOTOA625 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOTOA625 route product structure diagram
    ACOTOA625860787-68-4
Inquiry

Comments (0)